156 related articles for article (PubMed ID: 37305401)
1. Suppression of human papillomavirus type 16 E5 oncoprotein: A promising step in fostering the treatment of cervical cancer.
Hemmat N; Doustvandi MA; Asadzadeh Z; Mokhtarzadeh A; Baradaran B; Baghi HB
Oncol Res; 2021; 29(2):141-148. PubMed ID: 37305401
[TBL] [Abstract][Full Text] [Related]
2. Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis.
Chen B; Zhao L; Yang R; Xu T
Arch Biochem Biophys; 2023 Sep; 745():109716. PubMed ID: 37553047
[TBL] [Abstract][Full Text] [Related]
3. The papillomavirus E5 gene does not affect EGFR transcription and overall survival in cervical cancer.
Basto DL; Chaves CBP; Felix SP; Amaro-Filho SM; Vieira VC; Martins LFL; de Carvalho NA; Almeida LM; Moreira MÂM
J Med Virol; 2020 Aug; 92(8):1283-1289. PubMed ID: 31696949
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment.
Kim MK; Kim HS; Kim SH; Oh JM; Han JY; Lim JM; Juhnn YS; Song YS
Biochem Pharmacol; 2010 Dec; 80(12):1930-5. PubMed ID: 20643111
[TBL] [Abstract][Full Text] [Related]
5. E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line.
Wechsler EI; Tugizov S; Herrera R; Da Costa M; Palefsky JM
J Gen Virol; 2018 May; 99(5):631-644. PubMed ID: 29624161
[TBL] [Abstract][Full Text] [Related]
6. Impact of HPV E5 on viral life cycle via EGFR signaling.
Ilahi NE; Bhatti A
Microb Pathog; 2020 Feb; 139():103923. PubMed ID: 31836496
[TBL] [Abstract][Full Text] [Related]
7. Glycogene expression profiles from a HaCaT cell line stably transfected with HPV16 E5 oncogene.
Cisneros-Ramírez D; Martínez-Laguna Y; Martínez-Morales P; Aguilar-Lemarroy A; Jave-Suárez LF; Santos-López G; Reyes-Leyva J; Vallejo-Ruiz V
Mol Med Rep; 2020 Dec; 22(6):5444-5453. PubMed ID: 33174037
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical cancer.
Schrevel M; Gorter A; Kolkman-Uljee SM; Trimbos JB; Fleuren GJ; Jordanova ES
Mod Pathol; 2011 May; 24(5):720-8. PubMed ID: 21252859
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.
Woodworth CD; Diefendorf LP; Jette DF; Mohammed A; Moses MA; Searleman SA; Stevens DA; Wilton KM; Mondal S
Virology; 2011 Dec; 421(1):19-27. PubMed ID: 21982220
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance.
Scott ML; Woodby BL; Ulicny J; Raikhy G; Orr AW; Songock WK; Bodily JM
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666385
[TBL] [Abstract][Full Text] [Related]
11. Cellular Functions of HPV16 E5 Oncoprotein during Oncogenic Transformation.
Gutierrez-Xicotencatl L; Pedroza-Saavedra A; Chihu-Amparan L; Salazar-Piña A; Maldonado-Gama M; Esquivel-Guadarrama F
Mol Cancer Res; 2021 Feb; 19(2):167-179. PubMed ID: 33106372
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus 16 E2 interacts with neuregulin receptor degradation protein 1 affecting ErbB-3 expression in vitro and in clinical samples of cervical lesions.
Paolini F; Curzio G; Melucci E; Terrenato I; Antoniani B; Carosi M; Mottolese M; Vici P; Mariani L; Venuti A
Eur J Cancer; 2016 May; 58():52-61. PubMed ID: 26963794
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.
Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D
Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977
[TBL] [Abstract][Full Text] [Related]
14. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
15. The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1).
Pedroza-Saavedra A; Lam EW; Esquivel-Guadarrama F; Gutierrez-Xicotencatl L
Virology; 2010 Apr; 400(1):44-52. PubMed ID: 20144468
[TBL] [Abstract][Full Text] [Related]
16. Effects of human papillomavirus type 16 E7 protein on the growth of cervical carcinoma cells and immuno-escape through the TGF-beta1 signaling pathway.
Xu Q; Wang S; Xi L; Wu S; Chen G; Zhao Y; Wu Y; Ma D
Gynecol Oncol; 2006 Apr; 101(1):132-9. PubMed ID: 16269171
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor-dependent stimulation of differentiation by human papillomavirus type 16 E5.
Trammel J; Amusan O; Hultgren A; Raikhy G; Bodily JM
Virology; 2024 Feb; 590():109952. PubMed ID: 38103269
[TBL] [Abstract][Full Text] [Related]
18. Variable expression of the forgotten oncogene E5 in HPV-positive oropharyngeal cancer.
Um SH; Mundi N; Yoo J; Palma DA; Fung K; MacNeil D; Wehrli B; Mymryk JS; Barrett JW; Nichols AC
J Clin Virol; 2014 Sep; 61(1):94-100. PubMed ID: 25027574
[TBL] [Abstract][Full Text] [Related]
19. Quantitative measurement of human papillomavirus type 16 e5 oncoprotein levels in epithelial cell lines by mass spectrometry.
Sahab Z; Sudarshan SR; Liu X; Zhang Y; Kirilyuk A; Kamonjoh CM; Simic V; Dai Y; Byers SW; Doorbar J; Suprynowicz FA; Schlegel R
J Virol; 2012 Sep; 86(17):9465-73. PubMed ID: 22740411
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells.
Oh JM; Kim SH; Cho EA; Song YS; Kim WH; Juhnn YS
Carcinogenesis; 2010 Mar; 31(3):402-10. PubMed ID: 20015862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
